This finding, combined with previous reports showing that MerTK deficiency affects both efferocytosis and inflammation in lesions6, 7 suggests that MerTK is the dominant TAM receptor in these processes in the setting of atherosclerosis. This evidence concerns the gene MERTK and atherosclerosis.